Study of a new drug for advanced solid tumors
Treatments studied
Part of Cancer, Digestive system, Skin clinical trials.
This study tests a new intravenous drug called ABBV-400 in people with certain advanced solid tumors that have not responded to other treatments. The goal is to see if it can slow or stop tumor growth and to check for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these cancers: liver, pancreatic, bile duct, esophageal, breast, head and neck, or ovarian cancer that has spread or cannot be removed by surgery.
- Your cancer must be measurable on scans (like CT or MRI).
- You must have had prior cancer treatment (chemotherapy, radiation, immunotherapy, etc.) and stopped it at least 28 days before starting the study drug.
- You have no current or past lung problems like interstitial lung disease or pneumonitis that needed steroids.
- You have not had untreated brain metastases, or if you have had brain metastases, they are stable and you do not need steroids for brain swelling.
- You do not have another active cancer except for certain non-melanoma skin cancers or other early-stage cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, PF-08634404, alone or with other treatments for adults with advanced liver cancer that cannot be removed by surgery or has spread. It is for people who have not had prior systemic therapy and have good liver function.
This trial tests an investigational drug given through an IV to see if it can help people with advanced solid tumors. It aims to learn about side effects, how the drug works in the body, and whether it can slow or shrink the cancer.
This study tests new drug combinations for people with various advanced cancers that have progressed after standard treatment, or in some cases, as a first treatment. It aims to see if these combinations are safe and effective. The study is divided into groups based on cancer type and treatment history, so not everyone will qualify for every group.
This trial tests a new drug called ABBV901, given alone or with other anticancer drugs, for people with advanced ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see how well it works and how it affects the body.
This study tests an experimental IV drug (ABBV-324) for adults with advanced liver cancer (HCC) or advanced squamous lung cancer (LUSC). It aims to see if the drug is safe and whether it can help control the disease.
This study tests an oral drug called ABBV-711, alone or with another drug, for adults with advanced squamous cell cancers of the head, neck, or lung that have stopped responding to standard treatments. It aims to see how safe and effective the drug is.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.